Introduction {#S0001}
============

Inhibitory (Gi/o) G protein-coupled receptor signaling pathways regulate membrane excitability in many cell types, including neurons, endocrine cells and cardiac myocytes.[@CIT0001] G protein-gated inwardly rectifying potassium (GIRK) channels are common downstream effectors for PTX-sensitive Gi/o-dependent signaling pathways in the nervous system.[@CIT0002] The mechanisms underlying activation of GIRK channels have been explored and evidence shows that GIRK channels are activated by G~βγ~ subunits after the ligand binding with the corresponding G protein-coupled receptors.[@CIT0003],[@CIT0004] A well-established example is opioid-induced analgesia which involves GIRK channels acting as downstream effectors.[@CIT0005]--[@CIT0008] In addition, GIRK channels are known to mediate the inhibitory effects of many other neurotransmitters and drugs of abuse.[@CIT0009],[@CIT0010] GIRK channel subunits have been detected in dorsal root ganglion (DRG) neurons of rats and humans,[@CIT0011]--[@CIT0014] and mice.[@CIT0015],[@CIT0016] Opiates are known to be highly effective in acute pain and acute inflammatory pain,[@CIT0017]--[@CIT0021] but are less effective in neuropathic pain patients or animal models. After peripheral nerve injury, the GIRK1 and −2 proteins are significantly downregulated in DRGs and spinal dorsal horn.[@CIT0022] This suggests a possible loss of opioid-induced inhibition.

There are four GIRK subunits (GIRK1-4) in mammals, of which GIRK1 and −2 have splice variants, but not GIRK3 or GIRK4.[@CIT0023] Functional GIRK channels are composed of homotetramers or heterotetramers. GIRK3 cannot form functional homotetramers[@CIT0024] but rather assembles with other GIRK subunits to form functional channels. In addition, GIRK3 is suggested to regulate GIRK signaling differently from other GIRK subunits based on the findings that in GIRK2- and/or 1-knockout (KO) mice, a strong reduction of GIRK current is detected in the brain,[@CIT0025] however, GIRK3-KO mice exhibit similar currents induced by agonist but less severe sedatives induced withdrawal as compared to wild-type (WT) mice.[@CIT0026] In GIRK2-KO mice, massive behavioral abnormalities have been found, whereas GIRK3-KO mice are no different from WT mice in behavioral tests.[@CIT0001],[@CIT0027],[@CIT0028] Moreover, a lysosomal targeting sequence in GIRK3 can promote the degeneration of GIRK channels.[@CIT0029] All evidence above points out the significance of GIRK3 for GIRK channel function, which is different from other GIRK subunits.

Recently, the expression of GIRK1 and GIRK2 has been studied in rat lumbar (L) DRGs and spinal cord, and both subunits are downregulated by peripheral axotomy.[@CIT0022] In this study, the effects of nerve injury on GIRK3 expression were investigated in DRGs and spinal cord, and the axonal transport of GIRK3 was also analyzed.

Materials and Methods {#S0002}
=====================

Animals {#S0002-S2001}
-------

Adult male Sprague--Dawley rats (200--250 g, B&K Universal, Stockholm, Sweden) were used in this study. The rats were housed 2 or 3 per cage and allowed to access to food and water *ad libitum*. All experiments were performed according to the Ethical Guidelines of the International Association for the Study of Pain and were approved by the local research ethics committee (Stockholm's Norra Djurförsöksetiska Nämnd (N150/11)).

Surgical Procedures {#S0002-S2002}
-------------------

The surgery for a unilateral complete sciatic nerve transection (axotomy) was made according to a previous study.[@CIT0030] The rats subjected to axotomy were allowed to survive for 14 days. Dorsal root rhizotomy and sciatic nerve crush were performed according to previous procedures.[@CIT0031],[@CIT0032] Briefly, both skin and muscles were incised to expose vertebral laminae under deep anesthesia, followed by transection of L2-5 dorsal roots, and finally muscles and skin were sutured. The rats subjected to rhizotomy were allowed to survive for 14 days. The rats subjected to sciatic nerve crush were sacrificed 10 hrs postsurgery.

Immunohistochemistry {#S0002-S2003}
--------------------

All rats were deeply anesthetized with sodium pentobarbital (50 mg/kg, i.p.). The anaesthetic animals were transcardially perfused with 50 mL warm saline (0.9%; 37°C), followed by 50 mL 4% paraformaldehyde, and finally by 250 mL of the same, but ice-cold fixative. The contra- and ipsilateral DRGs (L4-5), as well as corresponding spinal cord at injured levels, were dissected out and post-fixed in the fixative for 90 min at 4°C. Subsequently, all specimens were stored in 10% sucrose at 4°C for 2 days. Tissues were embedded in OCT compound (Tissue Tek, Sakura, Leiden, Netherland), and then sectioned in a cryostat (Microm, Heidelberg, Germany) at 12 μm (DRGs) or 14 μm (hind paw skin and sciatic nerve), and 20 μm (spinal cord) thickness. Immunoreactivities were visualized by tyramide signal amplification system (TSA Plus; NEN Life Science Products, Boston, MA) as described previously.[@CIT0033] To perform colocalization study in DRG sections, adjacent ones (5 μm) were used for staining with different primary antibodies. In spinal cord, sciatic nerve or skin of hind paws, TSA Plus staining was performed, followed by indirect immunohistochemistry,[@CIT0034] visualized by lissamine rhodamine sulfonylchloride-conjugated donkey anti-rabbit or mouse antibodies (1:100; Jackson Immuno Research, West Grove, PA, USA). Information for primary antibodies used in this study was provided in [Table 1](#T0001){ref-type="table"}.Table 1Primary Antibody ListAntibodyHost SpeciesExperimentDilutionSupplier/Catalogue No.CharacterizationGIRK3RabbitIHC (TSA)1:5,000Professor M. WatanabeAguado et al[@CIT0035]GIRK3RabbitIHC (Coons)1:1,000Professor M. WatanabeAguado et al[@CIT0035]GIRK3RabbitWB1:400Professor M. WatanabeAguado et al[@CIT0035]CGRPRabbitIHC (Coons)1:2,000S.I. GrigisOrazzo et al[@CIT0046]NF200MouseIHC (Coons)1:400Sigma/N0142Perry et al[@CIT0047]GalRabbitIHC (Coons)1:4,000E. TheodorssonPerry et al[@CIT0047]NPYRabbitIHC (Coons)1:400Walsh and WongShi et al[@CIT0041]PGP9.5RabbitIHC (Coons)1:400Swant/PV 25Brumovsky et al[@CIT0048]β-actinMouseWB1:5000Sigma/A5441Lyu et al[@CIT0022]

The specificity of anti-GIRK3 polyclonal antibody was confirmed by immunohistochemistry using brain samples from GIRK3-KO mice.[@CIT0035] To detect IB4-binding neurons, the sections were incubated with isolectin B4 (IB4) (*Griffonia simplicifolia* I, 2.5 g/mL; Vector Laboratories, Burlingame, CA), followed by incubation with a goat anti-GSA I antiserum (1:2,000; Vector Laboratories).

Western Blot {#S0002-S2004}
------------

On day 14 following axotomy, the contra- and ipsilateral DRGs (L4-5) were respectively collected, and then immediately snap frozen on dry ice. The tissues were roughly broken with knife and placed in lysis buffer containing protease inhibitor (P8340; Sigma), followed by sonication. The lysates were centrifuged for 30 min under 10,000×g at 4 °C, and the supernatants were used for Western blot analysis according to our previous procedures.[@CIT0022] Briefly, 20 μg of protein was loaded on 10% SDS-PAGE gel and transferred to polyvinylidene fluoride membrane (Millipore, Hemel, Hempstead, UK). The anti-GIRK3 polyclonal antibody used in this study is known to recognize a protein of \~45 kD protein in WT cerebellum, but absent in either GIRK3-KO or GIRK2/3-KO mice.[@CIT0035] The β-actin was used as a loading control.

Image Analysis and Quantification {#S0002-S2005}
---------------------------------

The sections were analysed in a confocal scanning microscope (Bio-Rad, Hemel, Hempstead, UK) equipped with ×10 (0.5 NA), ×20 (0.75 NA) and ×63 oil (1.40 NA) objectives. In some experiments, a LSM 700 confocal microscope (Zeiss, Oberkochen, Germany) was used as described in previous studies.[@CIT0033],[@CIT0036] The quantification was performed following the same set as in a previous report.[@CIT0022]

Statistical Analysis {#S0002-S2006}
--------------------

The statistical results were expressed as mean ± SEM. Percentages of GIRK3 immunoreactive (-IR) neuron profiles (NPs) were evaluated by unpaired Student's *t*-test between contra- and ipsilateral DRGs. The band intensity in Western blot and fluorescence levels for GIRK3-like immunoreactivity (LI) in proximal and distal sciatic nerve was performed by densitometry with Image J software.

Results {#S0003}
=======

Expression of GIRK3 in Control DRGs {#S0003-S2001}
-----------------------------------

In this study, the immunofluorescent signal of GIRK3 was observed in rat DRGs but was undetectable when the anti-GIRK3 antibody was pre-incubated with the homologous antigen in an absorption test ([Figure 1A](#F0001){ref-type="fig"} vs. [D](#F0001){ref-type="fig"}). High power immunofluorescence micrographs showed that the GIRK3-LI was largely accumulated in a punctate pattern in the cytoplasm surrounding the nucleus ([Figure 1C](#F0001){ref-type="fig"}).Figure 1GIRK3 co-localizes with neuronal markers in control DRGs. (**A, B**) Arrows indicate the neurons expressing GIRK3 (**A**) and CGRP (**B**). (**C**) High magnification immunofluorescence micrograph shows punctate distribution of GIRK3-LI in the cytoplasm surrounding the nucleus. The dashed line indicates cellular border. The asterisk indicates nucleus. (**D**) GIRK3^+^ signal is absent after pre-incubation of the antibodies with 10^−6^ M immunogen in the absorption test. (**E**--**M**) GIRK3-LI (**E, H, K**) co-localizes with CGRP (**F**), IB4 (**I**) and NF200 (**L**) indicated by the arrows, respectively. (**G**), (**J**) and (**M**) are merged images. (**N**) Pie-graphs show the proportion of co-localization of GIRK3 with each marker in control DRGs. The labeled number indicates counted NPs. Scale bars indicate 100 μm (**A, B**), 50 μm (**E**--**M**) and 20 μm (**C, D**).

Based on previously described classification principle, DRG neurons were grouped into three subpopulations using neuronal markers calcitonin gene-related peptide (CGRP), IB4 and neurofilament 200 (NF200).[@CIT0037] CGRP, IB4 and NF200 were used to label small peptidergic, small non-peptidergic, and medium-sized and large myelinated neurons, respectively. GIRK3-LI was detected in peptidergic and non-peptidergic NPs with a broad size spectrum, including small, medium-sized and large ones ([Figure 1A](#F0001){ref-type="fig"}, [B](#F0001){ref-type="fig"} and [E](#F0001){ref-type="fig"}--[M](#F0001){ref-type="fig"}). Quantification results showed \~41%, \~48% and \~45% of GIRK3-IR NPs expressed CGRP, IB4 and NF200, respectively. Conversely, \~38%, 54% and \~44% CGRP-IR, IB4-IR and NF200-IR NPs expressed GIRK3, respectively ([Figure 1N](#F0001){ref-type="fig"}).

GIRK3 in Hind Paws and Sciatic Nerve {#S0003-S2002}
------------------------------------

In rat glabrous skin of hind paws, GIRK3-LI was seen within the dermis layer ([Figure 2A](#F0002){ref-type="fig"}--[C2](#F0002){ref-type="fig"}). GIRK3-LI co-localized with CGRP and PGP9.5 in nerve terminals ([Figure 2A](#F0002){ref-type="fig"}--[C2](#F0002){ref-type="fig"}, [D](#F0002){ref-type="fig"}--[F](#F0002){ref-type="fig"}). GIRK3-LI was intensively expressed in the nerve bundles, as well as epineurium in the dermal layer of the hind paw skin ([Figure 2G](#F0002){ref-type="fig"}--[I](#F0002){ref-type="fig"}). In addition, GIRK3-LI was also observed in non-neuronal cells ([Figure 2A2](#F0002){ref-type="fig"}--[C2](#F0002){ref-type="fig"}). GIRK3 was expressed in intact sciatic nerve and co-localized with CGRP, IB4 and PGP9.5, respectively ([Figure 3](#F0003){ref-type="fig"}).Figure 2Characteristics of GIRK3 expression in skin of hind paw. (**A**--**C**) A large amount of GIRK3-LI (**A**) is seen in upper dermis, some co-localize with CGRP^+^ fibers (**B**). (**A1, B1, C1**) High magnification of immunofluorescence micrographs shows the co-localized fibers of GIRK3-LI (**A1**; arrowheads) and CGRP-LI (**B1**; arrowheads). (**A2, B2, C2**) Some GIRK3^+^ (**A2**; arrowheads), but CGRP^−^ (**B2**; arrowheads) fibers are seen in the upper dermis. (**D**--**F**) GIRK3^+^ fibers (**D**; arrowheads) are also PGP9.5^+^ (**E**; arrowheads) in upper dermis. (**G**--**I**) GIRK3-LI (**G**) co-localizes with PGP9.5-LI (**H**) largely in nerve bundles (white arrowheads) and epineurium (yellow arrowheads) in lower dermis (**I**). Scale bars indicate 100 μm (**A**--**C, G**--**I**) and 20 μm (**A1**--**C2, D**--**F**).Figure 3Expression of GIRK3-LI in sciatic nerve. (**A**--**C**) Double-staining shows a few GIRK3^+^ fibers (**A**) are CGRP^+^ (**B**) in sciatic nerve. (**D**--**F**) Some GIRK3^+^ fibers (**D**) are IB4^+^ (**E**). (**G**--**I**) GIRK3-LI (**G**) in sciatic nerve shows co-localization with an axonal marker PGP9.5 (**H**). Arrowheads indicate the co-localization of GIRK3-LI with each marker in sciatic nerve. (C), (F), and (I) are merged images. Scale bar indicates 20 μm (**A**--**I**).

Upregulation of GIRK3 in Axotomized DRGs {#S0003-S2003}
----------------------------------------

On day 14 following axotomy, a significant upregulation in the percentage of GIRK3-IR NPs was observed in injured DRGs (ipsi vs. contra; 38.5 ± 0.9% vs. 17.1 ± 0.8%; \*\*\**p* \< 0.001, n = 5) ([Figure 4A](#F0004){ref-type="fig"}--[C](#F0004){ref-type="fig"}). The relative levels of GIRK3 were also confirmed to be upregulated in the ipsilateral as compared to contralateral DRGs (from two rats, the same side of DRGs was pooled) by Western blot ([Figure 4D](#F0004){ref-type="fig"}). Of note, only one strong band with predicted molecular weight was observed in the intact membrane for Western blot, further confirming the antibody specificity ([Figure 4D](#F0004){ref-type="fig"}).Figure 4GIRK3 is upregulated in DRGs 14 days after axotomy. (**A, B**) Immunofluorescence micrographs show GIRK3-LI in contra- and ipsilateral DRGs, respectively. (**C**) Quantification analysis shows percentage of GIRK3^+^ NPs is significantly higher in ipsilateral compared to contralateral DRGs after axotomy (n = 5 per group; \*\*\**p* \< 0.001). (**D**) Western blot shows total protein of GIRK3 in DRGs is upregulated after axotomy. (**E**--**G**) GIRK3 (**E**) co-localizes with NPY (**F**) shown by arrows in ipsilateral DRGs. (**H**--**J**) GIRK3 (**H**) co-localizes with Gal (**I**) shown by arrows in ipsilateral DRGs. (**G**) and (**J**) are merged images. (**K**) Pie-graphs show the proportion of DRG neurons exhibiting co-localization of GIRK3 with NPY and Gal in ipsilateral DRGs, respectively. The labeled numbers indicate counted NPs. Arrows indicate co-localized neurons in (**E**--**J**). Scale bars indicate 40 μm (**A, B**) and 50 μm (**E**--**J**).

The 29-amino acid neuropeptide (30 in humans) galanin (Gal) and the 36-amino acid neuropeptide Y (NPY) are often used as indicators of nerve injury-associated outcomes. Under normal condition, NPY is usually undetectable in rat DRGs but its mRNA and protein levels are dramatically increased, predominantly in medium-sized and large NPs, after peripheral nerve injury.[@CIT0038]--[@CIT0041] Gal is expressed in a small portion (\<5%) of DRG NPs, but is strongly upregulated (up to 50%) in injured DRGs, with peak levels on 7--14 days after axotomy, at both mRNA and protein levels.[@CIT0042],[@CIT0043] In the present study, \~56% and \~51% of GIRK3-positive (^+^) NPs co-expressed NPY and Gal 14 days after axotomy, respectively ([Figure 4E](#F0004){ref-type="fig"}--[K](#F0004){ref-type="fig"}). Conversely, \~85% of NPY^+^ and \~49% of Gal^+^ NPs were GIRK3^+^, respectively ([Figure 4E](#F0004){ref-type="fig"}--[K](#F0004){ref-type="fig"}).

Peripheral Nerve Injury Induced an Upregulation of GIRK3 in Spinal Dorsal Horn {#S0003-S2004}
------------------------------------------------------------------------------

GIRK3-LI was mainly observed in the superficial layers of dorsal horn ([Figure 5A](#F0005){ref-type="fig"}, [D](#F0005){ref-type="fig"} and [I](#F0005){ref-type="fig"}). The GIRK3-LI was absent in the absorption test ([Figure 5B](#F0005){ref-type="fig"}). CGRP^+^ fibers were found in lamina I and II with some extension to the deeper laminae ([Figure 5C](#F0005){ref-type="fig"}). GIRK3-IR interneurons were found in deeper laminae, but not superficial layers ([Figure 5D](#F0005){ref-type="fig"}, [E](#F0005){ref-type="fig"}, [G](#F0005){ref-type="fig"} and [H](#F0005){ref-type="fig"}). These interneurons were CGRP-negative ([Figure 5F](#F0005){ref-type="fig"}--[H](#F0005){ref-type="fig"}). An increase of GIRK3^+^ processes was detected in the ipsilateral as compared with the contralateral dorsal horn on day 14 after axotomy ([Figure 5I](#F0005){ref-type="fig"}).Figure 5Expression and regulation of GIRK3 in spinal cord. GIRK3-LI is present in control dorsal horn (**A**), and is absent after pre-incubation of the antibody with 10^−6^ M immunogen in the absorption test (**B**). (**C, D**) GIRK3-LI (**D**) is largely localized in the superficial laminae but much weaker than CGRP-LI (**C**), and also present in a few interneurons in deeper laminae (**E, G, H**). Representative micrographs show GIRK3^+^ (**G** and **H**; arrows) but CGRP^−^ (**F**; arrows) interneurons in deeper laminae (GIRK3, green; CGRP, red). (**I**) Fourteen days after axotomy, a dramatic upregulation of GIRK3-LI (red arrows) is seen on the ipsilateral (ipsi) as compared to contralateral (contra) spinal dorsal horn. Scale bars indicate 500 μm (**I**), 100 μm (**A**--**D**), 50 μm (**F**--**H**) and 25 μm (**E**).

Axonal Transport of GIRK3 {#S0003-S2005}
-------------------------

Spinal dorsal rhizotomy was performed unilaterally. After rhizotomy, CGRP-LI was largely reduced in the ipsilateral dorsal horn as compared with contralateral one ([Figure 6A](#F0006){ref-type="fig"} vs [B](#F0006){ref-type="fig"}). Similar to that of CGRP, GIRK3^+^ signals were mostly eliminated in the ipsilateral dorsal horn after rhizotomy, indicating an anterograde transport of GIRK3 from peripheral sensory neurons to central spinal cord ([Figure 6C](#F0006){ref-type="fig"} vs [D](#F0006){ref-type="fig"}). Sciatic nerve crush caused an accumulation of GIRK3 at the injured site where GIRK3-LI was significantly stronger in proximal than distal sites ([Figure 6E](#F0006){ref-type="fig"} and [F](#F0006){ref-type="fig"}), thus indicating both anterograde and retrograde transport of GIRK3 in DRG neurons.Figure 6Axonal transport of GIRK3. (**A**--**D**) Fourteen days after unilateral dorsal rhizotomy, both CGRP- and GIRK3-LIs are largely decreased (red arrows) in ipsilateral dorsal horn compared to contralateral one. (**E, F**) Ten hours after sciatic nerve crush (red arrows indicate injured site), significant more GIRK3-LI is accumulated on the proximal side of the crush (green arrows) than the distal side (n = 3; \*\**p* \< 0.01). Scale bars indicate 100 μm (**A**--**D**) and 50 μm (**E**).

Discussion {#S0004}
==========

We have recently investigated the expression and regulation of GIRK1 and −2 in rat DRGs and spinal cord following peripheral nerve injury.[@CIT0022] In the present study, similar methods have been employed to analyze the expression of GIRK3 in rat DRGs and spinal cord. GIRK3 was expressed in \~17% of the DRG NPs and significantly increased after axotomy (to around 39%). This contrasts with the expression of both GIRK1 and −2, for which the corresponding proportions in controls were \~70% and \<10%, respectively, and both were downregulated (to \~55% and \<2%, respectively). GIRK3 was also detected in the spinal dorsal horn and also increased after axotomy.

Using RNA-seq, Flegel and colleagues investigated the expression of G protein-coupled receptors and ion channels in human sensory ganglia, including DRGs and trigeminal ganglia.[@CIT0012] All GIRK channel subunits were found in human DRGs, with a highest expression level of GIRK1, lower expression levels of GIRK3 and GIRK4, and lowest expression level of GIRK2. Our previously published results[@CIT0022] and results presented in this study reveal a similar expression pattern of GIRK1-3 in rats compared to humans.

We further detected GIRK3-LI in all three major DRG neuron subpopulations, which include neurons expressing CGRP (small peptidergic), IB4 (small non-peptidergic) or NF200 (medium-sized and large myelinated Aß), whereby each of the three was found in 40\~50% of the GIRK3^+^ NPs. This means that there is a certain overlap, but the details still need to be sorted out. Moreover, and importantly, also GIRK1 coexpressed these three markers with the following percentages: \~17%, \~51% and \~39%.[@CIT0022] This indicates a potential for interaction of GIRK3 with GIRK1 to form heterotetramer channels in the subpopulations of DRG neurons. In contrast, none of the GIRK2^+^ neurons expressed CGRP, but a high percentage IB4 (\~73%) and a lower percentage NF200 (\~32%).[@CIT0022] Thus, our findings suggest a possible interaction between GIRK3 and GIRK2 in non-peptidergic and myelinated neurons. We found a large amount of GIRK3-LI surrounding the nucleus in the cytoplasm without clear membrane localization. This maybe because that GIRK3 lacks an endoplasmic reticulum (ER) export signal[@CIT0029] and therefore it is retained in the ER after translation. In addition, GIRK1 but not GIRK2 or 4 also lacks an ER export signal. Thus, the GIRK1 is mostly not seen on the membrane.[@CIT0022]

GIRK3^+^ processes were seen in the superficial layers of spinal dorsal horn, especially in the lamina II. Interestingly, GIRK1^+^ and GIRK2^+^ processes were also found abundantly in the lamina II. However, only accountable GIRK3^+^ interneurons were seen in the deeper spinal dorsal horn laminae. Thus, most of GIRK3^+^ fibers in the dorsal horn presumably originate in DRGs. This is supported by our findings (i) sciatic nerve crush causes an accumulation of GIRK3 on proximal side indicating the existence of anterograde fast axonal transport; and, especially, (ii) GIRK3-LI was completely eliminated in the ipsilateral dorsal horn after dorsal root rhizotomy. Thus, the majority of GIRK3 is located in the presynaptic terminals of sensory input to the spinal cord, indicating a role in modulating spinal nociceptive processing at the presynaptic level. In contrast, much more GIRK1 and −2 LIs were detected in local dorsal horn neurons. Moreover, both GIRK1 and −2 are axonally transported,[@CIT0022] and they are also present in afferent nerve endings. These two subunits may thus have both presynaptic actions as well as controlling signalling in postsynaptic dorsal horn interneurons.

It has been demonstrated that several types of potassium (K^+^) channel-components are downregulated by peripheral nerve injury in somatosensory system, including voltage-gated K^+^ channels, two-pore-domain K^+^ channels, calcium^2+^-activated K^+^ channels, ATP-sensitive K^+^ channels and inwardly-rectifying K^+^ channels.[@CIT0002],[@CIT0044],[@CIT0045] The activation of these K^+^ channels can induce K^+^ outflow and cause the membrane potential of neurons more negative, which is more inhibited. Here, we reported an upregulation of GIRK3 in both DRGs and dorsal horn following peripheral nerve injury, which is in contrast to the downregulation of most of the other K^+^ channel-components as listed above. These data reflect a unique and complex role of GIRK3 in the sensory neurons. Considering a role of GIRK3 in reducing the number of other GIRK channels on the cell surface by targeting other subunits to lysosome for degradation,[@CIT0029] the upregulation of GIRK3 may be a possible reason for the downregulation of GIRK1 and −2.

Gal and NPY are both strongly upregulated and have been shown to be involved in nociceptive processing, especially after peripheral nerve injury. Here, we observed that a high proportion of GIRK3^+^ neurons contained Gal and NPY-LIs, further supporting a role of GIRK3 in pain modulation.

Concluding Remarks {#S0005}
==================

This work was an extension of our previous study on GIRK1 and −2. Our aim was to investigate the expression and regulation of GIRK3 in sensory neurons after nerve injury. Together with our previously published data, a summary of expression of GIRK channel subunits 1--3, in rat DRGs and spinal dorsal horn, is as follows: Of the three channel subunits, GIRK1 has the highest level of protein.In contrast to the downregulation of GIRK1 and −2, GIRK3-LI is upregulated after peripheral nerve injury.
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